Initiates Coverage on Retractable Technologies (NYSE:RVP)

Research analysts at started coverage on shares of Retractable Technologies (NYSE:RVPGet Rating) in a research note issued on Thursday. The firm set a “buy” rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP traded up $0.04 during mid-day trading on Thursday, hitting $2.32. 25,870 shares of the company’s stock were exchanged, compared to its average volume of 37,633. Retractable Technologies has a twelve month low of $1.90 and a twelve month high of $9.11. The firm has a market cap of $76.42 million, a price-to-earnings ratio of 2.64 and a beta of 2.10. The company has a quick ratio of 4.89, a current ratio of 6.12 and a debt-to-equity ratio of 0.01.

About Retractable Technologies

(Get Rating)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with's FREE daily email newsletter.